|
⚲
|
| Keyboard |
| Shanafelt Armen
✚
|
|
|---|---|
| CIK # | 0001656151 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001656151] | |
| 4 | [0001656151] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Shanafelt Armen | |
| Surface Oncology Inc | |
| Spyre Therapeutics Inc | |
| Rein Therapeutics Inc | |
| Protagonist Therapeutics Inc | |
| Lilly Ventures Fund I LLC | |
| Torres S Edward |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Surface Oncology Inc SURF
Stock Option (Right to Buy) · derivative
|
2022-06-08 | Grant | 24,000 | $0.00 | |
|
Spyre Therapeutics Inc AGLE
Director Stock Option (right to buy) · derivative
|
2022-06-07 | Grant | 43,000 | $0.00 | |
|
Spyre Therapeutics Inc AGLE
Common Stock
|
2021-12-13 | Buy | 14,685 | $3.65 | 53,600 |
|
Spyre Therapeutics Inc AGLE
Common Stock
|
2021-12-10 | Buy | 13,516 | $3.65 | 49,333 |
|
Spyre Therapeutics Inc AGLE
Common Stock
|
2021-12-09 | Buy | 121,799 | $3.67 | 447,002 |
|
Surface Oncology Inc SURF
Stock Option (Right to Buy) · derivative
|
2021-06-08 | Grant | 17,700 | $0.00 | |
|
Spyre Therapeutics Inc AGLE
Director Stock Option (right to buy) · derivative
|
2021-06-08 | Grant | 40,000 | $0.00 | |
|
Surface Oncology Inc SURF
Stock Option (Right to Buy) · derivative
|
2020-06-10 | Grant | 12,000 | $0.00 | |
|
Spyre Therapeutics Inc AGLE
Director Stock Option (right to buy) · derivative
|
2020-06-08 | Grant | 28,100 | $0.00 | |
|
Surface Oncology Inc SURF
Stock Option (Right to Buy) · derivative
|
2019-10-01 | Grant | 16,531 | $0.00 | |
|
Surface Oncology Inc SURF
Stock Option (Right to Buy) · derivative
|
2019-07-01 | Grant | 6,937 | $0.00 | |
|
Spyre Therapeutics Inc AGLE
Director Stock Option (right to buy) · derivative
|
2019-06-07 | Grant | 12,400 | $0.00 | |
|
Surface Oncology Inc SURF
Stock Option (Right to Buy) · derivative
|
2019-06-05 | Grant | 12,100 | $0.00 | |
|
Rein Therapeutics Inc ALRN
Stock Option (right to buy) · derivative
|
2018-06-21 | Grant | 10,000 | $0.00 | |
|
Spyre Therapeutics Inc AGLE
Director Stock Option (right to buy) · derivative
|
2018-06-07 | Grant | 18,400 | $0.00 | |
|
Protagonist Therapeutics Inc PTGX
Stock Option (right to buy) · derivative
|
2018-05-29 | Grant | 12,000 | $0.00 | |
|
Surface Oncology Inc SURF
Common Stock
|
2018-04-23 | Buy | 266,000 | $15.00 | 3,990,000 |
|
Surface Oncology Inc SURF
Series A Preferred Stock · derivative
|
2018-04-23 | Conversion | 7,000,000 | ||
|
Surface Oncology Inc SURF
Common Stock
|
2018-04-23 | Conversion | 3,181,817 | ||
|
Spyre Therapeutics Inc AGLE
Director Stock Option (right to buy) · derivative
|
2017-12-01 | Grant | 30,000 | $0.00 | |
| showing 20 of 37 most recent transactions | |||||